ARCHIVES

Mendelsohn Defends ImClone’s Actions And His Role In Development of C225

This article is from The Cancer Letter archive.

Vol. 28 No. 38 | October 18, 2002

Download PDF Visit The Full Archive

Related Articles

ASCO Honors Eight With Special Awards

May 24, 2002

Senate Appropriations Committee Slashes NCI Funds By $25 Million

August 18, 1978

Clinical Trials Approved By NCI Last Month Are Listed

February 28, 2003

Mayo Clinic Cancer Center Wins NCI Support Grant Renewal

June 19, 2009

GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL

July 26, 2013

Sen. Bumpers Aims to Raise Health Research $$ With Cuts to Space Station, Supercollider, SDI

April 25, 1992